Biomarin Pharmaceutical reported $5.98B in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 717.67M 6.76M
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Acorda Therapeutics ACOR:US $ 466.09M 25.41M
Agios Pharmaceuticals AGIO:US $ 1541.5M 333.1M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Amgen AMGN:US $ 64993M 5220M
Arena Pharmaceuticals ARNA:US $ 901.03M 183.63M
Bayer BAYN:GR € 116549M 2122M
Biogen BIIB:US $ 23806.7M 663.7M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Gilead Sciences GILD:US $ 67098M 886M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Insmed INSM:US $ 1.31B 81.99M
Intercept Pharmaceuticals ICPT:US $ 523.07M 0.15M
IONIS PHARMACEUT IONS:US $ 2415M 82.07M
Moderna Inc MRNA:US 20.92B 4.77B
Neurocrine Biosciences NBIX:US $ 2017.3M 60.9M
Ptc Therapeutics PTCT:US $ 2007.32M 51.34M
Puma Biotechnology PBYI:US $ 226.29M 33.71M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Sangamo Biosciences SGMO:US $ 772.4M 62.96M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
Seattle Genetics SGEN:US $ 3977.88M 25.72M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M
United Therapeutics UTHR:US $ 5048.9M 204M
Vertex Pharmaceuticals VRTX:US $ 12618.74M 397.06M
YTE INCY:US $ 4198.83M 294.21M